Palo Capital’s Quest Diagnostics DGX Stock Holding History

Palo Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1.15M	Buy	13,788 +281	+2%	+$26.3K	0.49%	71
2018 Q3	$1.46M	Buy	13,507 +1,560	+13%	+$171K	0.52%	73
2018 Q2	$1.31M	Buy	11,947 +394	+3%	+$41K	0.48%	72
2018 Q1	$1.16M	Sell	11,553 -172	-1%	-$17.6K	0.42%	80
2017 Q4	$1.16M	Buy	11,725 +1,089	+10%	+$103K	0.52%	62
2017 Q3	$996K	Sell	10,636 -19	-0.2%	-$2.02K	0.53%	65
2017 Q2	$1.18M	Buy	10,655 +214	+2%	+$22.6K	0.67%	62
2017 Q1	$1.02M	Sell	10,441 -95	-0.9%	-$9.06K	0.6%	63
2016 Q4	$968K	Buy	10,536 +2,137	+25%	+$184K	0.61%	65
2016 Q3	$711K	Sell	8,399 -4,609	-35%	-$387K	0.49%	67
2016 Q2	$1.06M	Buy	13,008 +7,239	+125%	+$551K	0.36%	81
2016 Q1	$412K	Buy	+5,769	New	+$387K	0.32%	89

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Palo Capital's DGX Position: Q4 2018 in Review

Palo Capital increased its Quest Diagnostics (DGX) stake by 2.1% in Q4 2018, buying an estimated $26.3K and bringing the position to 13,788 shares worth $1.15M. The position accounts for 0.49% of the portfolio, ranked #71.

Palo Capital first reported a position in DGX in Q1 2016 and has held it in 12 quarters since. The position peaked at $1.46M in Q3 2018. 625 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

Palo Capital held 13,788 shares of Quest Diagnostics worth $1.15M as of Q4 2018.
Palo Capital bought 281 Quest Diagnostics shares in Q4 2018, an estimated $26.3K.
Quest Diagnostics made up 0.49% of Palo Capital's portfolio in Q4 2018, its #71 holding.
Palo Capital first reported a position in Quest Diagnostics in Q1 2016 and has held it in 12 quarters since.
Palo Capital's Quest Diagnostics position peaked at $1.46M in Q3 2018.
625 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.